The Effect of Erythropoietin on Ovarian Epithelium Karyorrhexis during Ischemia Reperfusion Injury in Rats

Research Article

Austin J Obstet Gynecol. 2015;2(2):1041.

The Effect of Erythropoietin on Ovarian Epithelium Karyorrhexis during Ischemia Reperfusion Injury in Rats

C. Tsompos¹*, C. Panoulis², K Τοutouzas³, G.Ζografos4 and A. Papalois5

¹Department of Obstetrics & Gynecology, Messolonghi County Hospital, Greece

²Department of Obstetrics & Gynecology, Aretaieion Hospital, Athens University, Greece

³Department of Surgery, Ippokrateion General Hospital,Athens University, Greece

4Department of Surgery, Ippokrateion General Hospital, Athens University, Greece

5Director, Experimental Research Center ELPEN Pharmaceuticals, Greece

*Corresponding author: Tsompos Constantinos,Department of Obstetrics & Gynecology, Mesologi County Hospital, Nafpaktou street, Mesologi 30200, Etoloakarnania, Greece

Received: May 31, 2015; Accepted: June 07, 2015; Published: June 10, 2015

Abstract

The aim of this experimental study was to examine the effect of erythropoietin on rat model and particularly in an ovarian ischemia reperfusion (IR) protocol. The effect of that molecule was studied pathologically using the mean ovarian epithelium karyorrhexis (OK) lesions. Materials and methods: 40 rats of mean weight 247.7 g were used in the study. OK lesions were evaluated at 60 min (groups A and C) and at 120 min (groups B and D) of reperfusion. Erythropoietin was administered only in groups C and D. Results were that Epo administration non-significantly decreased the OK scores by 0.15 without lesions [-0.371518 - 0.071518] (p= 0.1679). Reperfusion time non-significantly increased the OK scores by 0.1 without lesions [-0.27768095 – 0.14211844] (p=0.4073). However, Epo administration and reperfusion time together non-significantly decreased the OK scores by 0.0818182 without lesions [-0.2159977 - 0.0523614] (p=0.2246). Conclusions: Results of this study indicate that Epo administration interacted or not with reperfusion time non-significantly short-term decreased the OK scores. Perhaps, a longer study time than 2 hours may provide more significant effects.

Keywords: Ischemia; Erythropoietin; Ovarian epithelium karyorrhexis; Reperfusion

Introduction

Tissue Ischemia and Reperfusion (IR) remain of the main causes of permanent or transient damage with serious implications on adjacent organs and certainly on patients’ health. Although important progress has been made regarding the usage of erythropoietin (Epo) in managing of this kind of damages, satisfactory answers have not been given yet to fundamental questions, as, by what velocity this factor acts, when it should be administered, and in which dosage. The particularly satisfactory action of Epo in stem blood cells recovery has been noted in several performed experiments. However, just few relative reports were found concerning Epo trial in IR experiments, not covering completely this particular matter. A meta-analysis of 13 published [1] seric variables, coming from the same experimental setting, tried to provide a numeric evaluation of the Epo efficacy for the same endpoints. (Table 1). Also, a lot of publications addressed trials of other similar molecules of growth factors to which the studied molecule also belongs to. The aim of this experimental study was to examine the effect of Epo on rat model and particularly in an ovarian IR protocol. The effect of that molecule was studied by evaluating mean ovarian Epithelium Karyorrhexis (OK) lesions.